<--- Back to Details
First PageDocument Content
Biology / Molecular biology / Biotechnology / Nature / Hoffmann-La Roche / Genentech / South San Francisco /  California / Tissue plasminogen activator / Recombinant DNA / Polymerase chain reaction / Growth hormone treatment / Trastuzumab
Date: 2005-08-06 16:58:13
Biology
Molecular biology
Biotechnology
Nature
Hoffmann-La Roche
Genentech
South San Francisco
California
Tissue plasminogen activator
Recombinant DNA
Polymerase chain reaction
Growth hormone treatment
Trastuzumab

Digital Unix 4.0 Upgrade Plan

Add to Reading List

Source URL: www.cgl.ucsf.edu

Download Document from Source Website

File Size: 381,87 KB

Share Document on Facebook

Similar Documents

Large ElectronPositron Collider

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document